Amunix is committed to forming strong and effective partnerships with leading biotechnology and pharmaceutical companies that share our interest to discover, develop and deliver innovative and highly effective therapeutics.

Amunix believes in the power of partnerships and collaborative efforts, and has a long history of joint research and development projects. Together with our partners, we have advanced the development of novel therapeutics to treat cancer, gastrointestinal diseases, hormone deficiencies, blood disorders, and more.

Partnership brings you the opportunity to significantly improve the safety, efficacy and dosing schedules of pharmaceuticals. Amunix provides services and XTEN-based materials that support the goals and objectives of both parties at all stages in the development process.

If you are interested in exploring a collaboration or discussing other emerging opportunities, please contact us by emailing